ZOSTAVAX in Persons Imminently Receiving Chemotherapy for Solid Organ Tumors
Status:
Unknown status
Trial end date:
2018-05-01
Target enrollment:
Participant gender:
Summary
This study evaluates if the shingles vaccine works in those persons that receive it before
they receive chemotherapy for solid organ tumors. Half of the participants will receive the
ZOSTAVAX shingle vaccine and half of the participants will not received anything.